Medicine and HealthNature Communications
Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21
S. S. Leventhal, T. Bisom, et al.
Discover groundbreaking research on the Crimean-Congo Hemorrhagic Fever Virus, revealing how a self-replicating RNA vaccine induces neutralizing antibodies and protective immunity through TRIM21. This exciting study by Shanna S Leventhal and colleagues sheds new light on the mechanisms of protection against this lethal virus.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Health and Fitness
Risk of yellow fever virus transmission in the Asia-Pacific region
L. D. G. D. Lataillade, M. Vazeille, et al.
Medicine and Health
Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir
G. Bolcato, M. Bissaro, et al.
Medicine and Health
SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
M. Dogan, L. Kozhaya, et al.
Environmental Studies and Forestry
Virus-pathogen interactions improve water quality along the Middle Route of the South-to-North Water Diversion Canal
T. Chen, T. Liu, et al.
